deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT00056290

VEGF Gene Transfer for Diabetic Neuropathy

p.VGI.1 (VEGF2) Gene Transfer for Diabetic Neuropathy

Sponsor: Losordo, Douglas, M.D.

Conditions Diabetic Neuropathy
Interventions VEGF
Updated 6 times since 2017 Last updated: Nov 10, 2010 Started: Dec 31, 2002 Primary completion: Apr 30, 2008 Completion: Apr 30, 2008
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Diabetic Neuropathy, this trial is completed. The trial is conducted by Losordo, Douglas, M.D. and has accumulated 6 data snapshots since 2002. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

  5. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE1_PHASE2

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE1_PHASE2

    First recorded

Dec 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Losordo, Douglas, M.D.
Data source: Losordo, Douglas, M.D.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations